Over 1.1M people using GLP-1 drugs without FDA-approved reason
(NewsNation) — A new study published in Obesity Journal found more than 1.1 million people in the United…
Frailty linked to greater cognitive impairment risk in men with chronic kidney disease
New research from the University of Colorado Anschutz Department of Medicine is shedding light on how women and…
Kidney disease of unknown origin spreads in US. Who is at risk?
(NEXSTAR) – Doctors in Texas say they have seen an increasing number of otherwise healthy young men coming…
FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney Disease
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…
Are People With Eating Disorders Misusing GLP-1 Drugs?
Among over 400 people with eating disorders in an interim analysis of an ongoing cross-sectional study, 32.1% said…
Semaglutide and Ozempic-like drugs may improve kidney disease outcomes
Semaglutide, a medication commonly sold as Ozempic or Wegovy, is typically associated with weight loss. But it can…
Husband loses 4 stone to donate kidney to his wife
A woman from Shropshire says she feels ’emotional’ after her husband lost weight to donate his kidney to…
Following the EAT-Lancet diet lowers chronic kidney disease risk
Large-scale UK Biobank data show that the EAT-Lancet planetary health diet is associated with lower CKD risk, with…
Fitness coach shares ‘why young Malaysians are losing their kidneys’; some as young as 40
Rising cases of kidney problems are being reported among young adults in Malaysia, with lifestyle factors, poor diet,…
Simple fruit granola intervention shows promising cardio-renal signals in CKD patients
A small Japanese study suggests that a low-salt, oat-based granola breakfast may improve blood pressure, lipid risk markers,…
Difference in kidney function tests predicts health risks
December 16, 2025 At a Glance People with chronic kidney disease faced a higher risk of death and…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…